Associated Papers
Evaluation of Cystic Fibrosis Newborn Screening and Follow-Up Process in Georgia (2022-2023).
Vardosanidze N et al.
International Journal of Neonatal Screening, 2025
Benchmarking AlphaMissense Pathogenicity Predictions Against Cystic Fibrosis Variants.
McDonald EF et al.
Biorxiv : the Preprint Server for Biology, 2024
37873426 (PubMed )
Supplement: media-4.xlsx › Sheet1
Benchmarking AlphaMissense pathogenicity predictions against cystic fibrosis variants.
McDonald EF et al.
Plos One, 2024
38271453 (PubMed )
Supplement: pone.0297560.s010.xlsx › Supp_Table_3
Current Status of Genetic Diagnosis Laboratories and Frequency of Genetic Variants Associated with Cystic Fibrosis through a Newborn-Screening Program in Turkey.
Bozdogan ST et al.
Genes, 2021
Two years of newborn screening for cystic fibrosis in Turkey: Çukurova experience.
Şaşihüseyinoğlu AŞ et al.
The Turkish Journal of Pediatrics, 2019
Select a paper to view details